TTC Oncology

TTC Oncology

Innovating Safer Solutions for the Treatment of Metastatic Breast Cancer

Security Type
Min Investment
Minneapolis, MN
Offering Date
September 10, 2021
Expected Close Date
December 09, 2021

Company Description

Founded in 2015 as an R&D, pre-revenue startup, TTC Oncology’s mission is to develop and bring to market a novel, small-molecule therapy to address unmet needs of breast cancer patients. TTC Oncology has a license from the University of Illinois at Chicago covering the therapy associated with modulation and mimicry of estrogen actions. TTC Oncology completed a Phase I trial of their proprietary drug at four clinical sites under the guidance of breast cancer oncologists and consultants with extensive experience in pharma and biotech.  TTC Oncology has $6.2 million invested today. With drug safety established in the Phase I study, TTC Oncology is seeking investment to complete international pivotal Phase II clinical trials that are in preparation.

Key Deal Facts

Novel mechanism of action therapy for hormone resistant of breast cancer.
Intellectual property protected until 2033.
Safe and well tolerated oral capsule therapy.
Biomarker that identifies breast cancer that will respond well to TTC-352.
Completed first in human clinical trial.

Management Team / Advisory Board Bios

Arkadiusz Dudek
Chief Executive Officer
Fundraising that allowed completion of phase 1 clinical trial.

Arkadiusz Dudek, Chief Medical Officer
Completion of Phase 1 clinical trial with TTC352

Debra Tonetti, Chief Scientific Officer
Discovery of biomarker of resistance to hormonal therapy.
Amount Raised : $0
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

A SAFE is an agreement between you—the investor—and the company in which the company promises to give you a future equity stake based on the amount you invested. It also involves some kind of a triggering event that must take place in order for you to get your future equity stake. Be careful as you may only get equity if a particular event is triggered.

Research Reports

No reports have been submitted

Become a Reporter